Life Chemicals Sponsors “Advances in Screening Technologies for Drug Discovery”

Life Chemicals is proud to sponsor the Advances in Screening Technologies for Drug Discovery, taking place on December 5, 2025, in Paris, France. Organized by the Société de Chimie Thérapeutique (SCT) and ChemBioFrance, this one-day meeting will spotlight cutting-edge innovations shaping the next generation of screening and early drug discovery.

As a company committed to scientific innovation, we are pleased to contribute to this event and present our most advanced tools for hit discovery:

• Extensive HTS Compound Collection of over 575,000 stock drug-like molecules synthesized in-house
• Targeted and Focused Screening Libraries: GPCR, kinase, protease, PPI, CNS, antiviral, antibacterial, agrochemical and many more
• Fragment-Based Libraries for FBDD: 3D-shaped, Fsp³-rich, covalent and high-solubility fragment sets
• Screening-Ready Formats: pre-plated 96-/384-well sets, 10 mM DMSO solutions, custom subsets and robotics-compatible delivery
• Virtual Chemical Space: LifeCheMyriads sparkling with first constellations of 50 billion feasible molecules for custom synthesis

We warmly invite all attendees to visit our poster presentation “Next-generation Compound Libraries: From Virtual to High-throughput Screening”. The Company’s representative, Dr. Anna Zaitseva, will be happy to provide detailed insight into our unique medicinal chemistry, cheminformatics and the whole range of products and services.

Join her to exchange ideas and open up wide partnership opportunities! Accelerate hit discovery by integrating into your projects Life Chemicals Collection’s diversity, advanced in silico tools and high-throughput screening workflows.

For meeting arrangements, please contact: